Արգենտինա - իսպաներեն - SANI (Asociación de Cooperativas Argentinas)

agroinsumos s. a. - ampicilina sódica; ampicilina benzatínica; agua bidestilada apirógena estéril c.s.p. - ampicilina sódica 10 g.; ampicilina benzatínica 10 g.; agua bidestilada apirógena estéril c.s.p. 100 ml. - la ampicilina es un antibiótico betalactámico que pertenece al grupo de las aminopenicilinas, y éstas actúan muy bien sobre microorganismos gram-negativos y bastante bien también, sobre bacterias gram-positivas. la combinación de la forma sódica y benzatínica le otorga a esta asociación la posibilidad de lograr una rápida acción (forma sódica) y mantener la misma por un período más prolongado (forma benzatínica) aumentado de esta forma el intervalo entre dosis, con lo cual se incrementa la practicidad del t - equinos

Բրազիլիա - պորտուգալերեն - ANVISA (Agência Nacional de Vigilância Sanitária)

ems s/a - ampicilina, ampicilina tri-hidratada - penicilina de amplo espectro

Բրազիլիա - պորտուգալերեն - ANVISA (Agência Nacional de Vigilância Sanitária)

prati donaduzzi & cia ltda - ampicilina - penicilina de amplo espectro

Բրազիլիա - պորտուգալերեն - ANVISA (Agência Nacional de Vigilância Sanitária)

eurofarma laboratÓrios s.a. - ampicilina anidra - penicilina de amplo espectro

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

wg critical care, llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin for injection, usp is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: respiratory tract infections caused by s. pneumoniae, staphylococcus aureus (penicillinase and non-penicillinase producing), h. influenzae and group a beta-hemolytic streptococci. bacterial meningitis caused by e. coli, group b streptococci, and other gram-negative bacteria (listeria monocytogenes, n. meningitidis ). the addition of an aminoglycoside with ampicillin may increase its effectiveness against gram-negative bacteria. septicemia and endocarditis caused by susceptible gram-positive organisms including streptococcus spp., penicillin-g-susceptible staphylococci and enterococci. gram-negative sepsis caused by e. coli, proteus mirabilis and salmonella spp. responds to ampicillin. endocarditis due to enterococcal strains usually respond to intravenous therapy. the addition of an aminoglycoside may enhance the effectiveness of ampicillin when treating streptococcal endocarditis. urinary tract infections caused by sensitive strains of e. coli and proteus mirabilis . gastrointestinal infections caused by salmonella typhi (typhoid fever), other salmonella spp. and shigella spp. (dysentery) usually respond to oral or intravenous therapy. bacteriology studies to determine the causative organisms and their susceptibility to ampicillin should be performed. therapy may be instituted prior to obtaining results of susceptibility testing. it is advisable to reserve the parenteral form of this drug for moderately severe and severe infections and for patients who are unable to take the oral forms. a change to oral ampicillin may be made as soon as appropriate. indicated surgical procedures should be performed. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin for injection, usp and other antibacterial drugs, ampicillin for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. a history of a previous hypersensitivity reaction to any of the penicillins is a contraindication.

Պորտուգալիա - պորտուգալերեն - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

zentiva portugal, lda. - amoxicilina + Ácido clavulânico - pó para suspensão oral - 600 mg/5 ml + 42.9 mg/5 ml - amoxicilina tri-hidratada 137.76 mg/ml ; clavulanato de potássio diluído 20.44 mg/ml - amoxicillin and beta-lactamase inhibitor - genérico - duração do tratamento: curta ou média duração

Պորտուգալիա - պորտուգալերեն - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

zentiva portugal, lda. - amoxicilina + Ácido clavulânico - pó para suspensão oral - 600 mg/5 ml + 42.9 mg/5 ml - amoxicilina tri-hidratada 137.76 mg/ml ; clavulanato de potássio diluído 20.44 mg/ml - amoxicillin and beta-lactamase inhibitor - genérico - duração do tratamento: curta ou média duração

Պորտուգալիա - պորտուգալերեն - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

zentiva portugal, lda. - amoxicilina + Ácido clavulânico - pó para suspensão oral - 600 mg/5 ml + 42.9 mg/5 ml - amoxicilina tri-hidratada 137.76 mg/ml ; clavulanato de potássio diluído 20.44 mg/ml - amoxicillin and beta-lactamase inhibitor - genérico - duração do tratamento: curta ou média duração

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin 500 mg - ampicillin capsules, usp are indicated in the treatment of infections caused by susceptible strains of the designated organism listed below: infections of the genitourinary tract including gonorrhea: e. coli, p. mirabilis, enterococci, shigella , s. typhosa and other salmonella , and nonpenicillinase producing n. gonorrhoeae . infections of the respiratory tract: nonpenicillinase- producing h. influenzae and staphylococci, and streptococci including streptococcus pneumoniae . infections of the gastrointestinal tract: shigella, s. typhosa and other salmonella, e. coli, p. mirabilis, and enterococci. meningitis: n. meningitides . to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin and other antibacterial drugs, ampicillin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bact

Ֆրանսիա - ֆրանսերեն - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

pfizer holding france - ampicilline base 1 g sous forme de : ampicilline sodique 1; sulbactam 0 - poudre - 1 g - pour un flacon > ampicilline base 1 g sous forme de : ampicilline sodique 1,196 g > sulbactam 0,5 g sous forme de : sulbactam sodique 0,615 g - ampicilline et inhibiteur d’enzyme - classe pharmacothérapeutique : associations de pénicillines, incluant les inhibiteurs de bêta-lactamase - code atc : j01cr01.ce médicament associe un antibiotique antibactérien, l’ampicilline (antibiotique de la famille des bêta-lactamines du groupe des aminopénicillines) et le sulbactam (qui augmente l’effet de l’antibiotique).unacim est un antibiotique injectable de la classe des pénicillines, associé à un inhibiteur des bêta-lactamases (empêchant la destruction de l’antibiotique par certaines enzymes), qui sera toujours préparé et administré par un professionnel de santé.votre médecin vous a prescrit unacim : parce que vous avez une (ou plusieurs) des infections suivantes : respiratoire, oto-rhino-laryngologique, rénale, urinaire, gynécologique, digestive et biliaire, cutanée et sous cutanée, osseuse et articulaire, à l’exclusion des méningites. ou dans le cadre de la prévention des infections à germes sensibles en chirurgie abdominale et gynécologique.